Xiaoping Wan

1.5k total citations
30 papers, 1.2k citations indexed

About

Xiaoping Wan is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xiaoping Wan has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 21 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Xiaoping Wan's work include Cancer-related molecular mechanisms research (18 papers), MicroRNA in disease regulation (16 papers) and Circular RNAs in diseases (9 papers). Xiaoping Wan is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), MicroRNA in disease regulation (16 papers) and Circular RNAs in diseases (9 papers). Xiaoping Wan collaborates with scholars based in China, United States and Brazil. Xiaoping Wan's co-authors include Te Liu, Yinyan He, Weiwei Cheng, Hui Wang, Yongtao Gao, Yan Qin, Yixia Yang, Bin Cai, Xuelian Liu and Tingting Yang and has published in prestigious journals such as Circulation, Bioresource Technology and Cell stem cell.

In The Last Decade

Xiaoping Wan

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Wan China 19 836 661 173 137 87 30 1.2k
Zhengzheng Wei United States 12 502 0.6× 272 0.4× 185 1.1× 50 0.4× 104 1.2× 17 1.1k
Long Zhou China 16 510 0.6× 352 0.5× 91 0.5× 97 0.7× 76 0.9× 42 786
Çagatay Güneş Germany 20 631 0.8× 114 0.2× 182 1.1× 113 0.8× 113 1.3× 51 1.3k
Jill L. Reiter United States 15 384 0.5× 129 0.2× 227 1.3× 80 0.6× 73 0.8× 35 847
Ernesto Soto‐Reyes Mexico 17 623 0.7× 220 0.3× 123 0.7× 91 0.7× 53 0.6× 41 915
Qi Che China 22 578 0.7× 395 0.6× 188 1.1× 92 0.7× 117 1.3× 30 948
Hélène Buteau-Lozano France 8 287 0.3× 132 0.2× 127 0.7× 125 0.9× 51 0.6× 8 522
Zhanhui Ou China 12 1.8k 2.2× 1.2k 1.8× 244 1.4× 107 0.8× 105 1.2× 32 2.6k
Sihan Wu China 18 846 1.0× 676 1.0× 157 0.9× 66 0.5× 97 1.1× 49 1.4k

Countries citing papers authored by Xiaoping Wan

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wan more than expected).

Fields of papers citing papers by Xiaoping Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wan. The network helps show where Xiaoping Wan may publish in the future.

Co-authorship network of co-authors of Xiaoping Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Wan. A scholar is included among the top collaborators of Xiaoping Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Wan. Xiaoping Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, C M, Drew Nassal, Xianyao Xu, et al.. (2025). The two-pore K+ channel TREK-1 regulates pressure overload-induced cardiac remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 329(1). H178–H190.
2.
Lin, Qin, et al.. (2022). JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway. Cell Communication and Signaling. 20(1). 177–177. 5 indexed citations
3.
Yang, Dandan, Xiaoping Wan, Adrienne T. Dennis, et al.. (2021). MicroRNA Biophysically Modulates Cardiac Action Potential by Direct Binding to Ion Channel. Circulation. 143(16). 1597–1613. 43 indexed citations
4.
Li, Jiarong, Zhipeng Zheng, Junkai Zhang, Yunqiang Tang, & Xiaoping Wan. (2021). miR-449a regulates biological functions of hepatocellular carcinoma cells by targeting SATB1.. PubMed. 25(3). 1375–1382. 3 indexed citations
6.
Han, Tong, Yukang Wu, Xiang Hu, et al.. (2020). NORAD orchestrates endometrial cancer progression by sequestering FUBP1 nuclear localization to promote cell apoptosis. Cell Death and Disease. 11(6). 473–473. 22 indexed citations
7.
Bian, Yiding, et al.. (2019). ITE, an endogenous aryl hydrocarbon receptor ligand, suppresses endometrial cancer cell proliferation and migration. Toxicology. 421. 1–8. 17 indexed citations
8.
Li, Yiran, Yiding Bian, Kai Wang, & Xiaoping Wan. (2019). POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction. BMC Medical Genetics. 20(1). 202–202. 27 indexed citations
9.
Guo, Xudong, Yanxin Xu, Zikang Wang, et al.. (2018). A Linc1405/Eomes Complex Promotes Cardiac Mesoderm Specification and Cardiogenesis. Cell stem cell. 22(6). 893–908.e6. 72 indexed citations
10.
Wan, Xiaoping, Mingming Gao, Maosheng Ye, et al.. (2017). Formation, characteristics and microbial community of aerobic granular sludge in the presence of sulfadiazine at environmentally relevant concentrations. Bioresource Technology. 250. 486–494. 56 indexed citations
11.
Li, Bilan, Wen Lu, Junjie Qu, Yongli Zhang, & Xiaoping Wan. (2017). DICER1 regulates endometrial carcinoma invasion via histone acetylation and methylation. Journal of Cancer. 8(6). 933–939. 9 indexed citations
12.
Zhang, Yongli, et al.. (2016). SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line. Cancer Cell International. 16(1). 29–29. 15 indexed citations
13.
He, Xiaoying, Yun Liao, Wen Lu, et al.. (2016). Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma. Tumor Biology. 37(7). 9951–9958. 22 indexed citations
14.
Su, Ning, Haifeng Qiu, Yifei Chen, et al.. (2013). miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. Oncology Reports. 29(6). 2297–2302. 59 indexed citations
15.
Lu, Wen, Cong Lu, Junjie Qu, et al.. (2013). CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer. Cancer Cell International. 13(1). 44–44. 32 indexed citations
16.
Lu, Cong, et al.. (2013). miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer. Medical Oncology. 30(1). 484–484. 56 indexed citations
17.
Wu, Xiaomei, Xiaowei Xi, Yan Qin, et al.. (2013). MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition. Medical Oncology. 30(4). 751–751. 45 indexed citations
18.
Cheng, Weiwei, Te Liu, Xiaoping Wan, Yongtao Gao, & Hui Wang. (2012). MicroRNA‐199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer‐initiating cells. FEBS Journal. 279(11). 2047–2059. 201 indexed citations
19.
Jiang, Feizhou, Te Liu, Yinyan He, et al.. (2011). MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer. 11(1). 425–425. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026